Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 4Lymphoma, Non-Hodgkin 3Central Nervous System Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma 2Inflammatory Breast Neoplasms 2Brain Neoplasms 2Astrocytoma 2Rhabdoid Tumor 1Ovarian Neoplasms 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Multiple Myeloma 1Medulloblastoma 1Lymphoma, Large-Cell, Anaplastic 1Leukemia, Myeloid 1Leukemia, Lymphocytic, Chronic, B-Cell 1Intracranial Non-germinomatous Germ Cell Tumor 1Hodgkin Disease 1Graft vs Host Disease 1Fallopian Tube Neoplasms 1Choroid Plexus Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Melphalan 2Carboplatin 2sodium thiosulfate 1Verteporfin 1Thiotepa 1TH 302 1Surveys and Questionnaires 1Mannitol 1Etoposide 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Neuroectodermal Tumors, Primitive × Thiotepa × Clear all
NCT00180791 2007-09-18

High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Unknown
71 enrolled
CNS

Brain Neoplasms, Medulloblastoma, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡